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Abstract
Background: Maternal gestational diabetes (GDM) is an established risk factor for large size at birth, but its influence
on intrauterine fetal growth in different ethnic populations is less well understood. Here, we examine the joint
associations of GDM and ethnicity with longitudinal fetal growth in South Asian and White European origin women.
Methods: This study included 10,705 singletons (4747 White European and 5958 South Asian) from a prospective
cohort of women attending an antenatal clinic in Bradford, in the North of England. All women completed a 75-g oral
glucose tolerance test at 26–28 weeks’ gestation. Ultrasound measurements of fetal head circumference (HC), femur
length (FL) abdominal circumference (AC), and estimated fetal weight (EFW), and corresponding anthropometric
measurements at birth were used to derive fetal growth trajectories. Associations of GDM and ethnicity with these
trajectories were assessed using multilevel fractional polynomial models.
Results: Eight hundred thirty-two pregnancies (7.8%) were affected by GDM: 10.4% of South Asians and 4.4% of White
Europeans. GDM was associated with a smaller fetal size in early pregnancy [differences (95% CI) in mean HC at
12 weeks and mean AC and EFW at 16 weeks comparing fetuses exposed to GDM to fetuses unexposed
(reference) = − 1.8 mm (− 2.6; − 1.0), − 1.7 mm (− 2.5; − 0.9), and − 6 g (− 10; − 2)] and a greater fetal size from
24 weeks’ gestation through to term [differences (95% CI) in mean HC, AC, and EFW comparing fetuses
exposed to GDM to those unexposed = 0.9 mm (0.3; 1.4), 0.9 mm (0.2; 1.7), and 7 g (0; 13) at 24 weeks].
Associations of GDM with fetal growth were of similar magnitude in both ethnic groups. Growth trajectories,
however, differed by ethnicity with South Asians being smaller than White Europeans irrespective of GDM status.
Consequently, South Asian fetuses exposed to GDM were smaller across gestation than fetuses of White
Europeans without GDM.
Conclusions: In both ethnic groups, GDM is associated with early fetal size deviations prior to GDM diagnosis,
highlighting the need for novel strategies to diagnose pregnancy hyperglycemia earlier than current methods.
Our findings also suggest that ethnic-specific fetal growth criteria are important in identifying hyperglycemia-
associated pathological effects.
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Background
Gestational diabetes (GDM), which affects up to 10% of
pregnancies depending on the population under study
and diagnostic criteria applied, is associated with excess
fetal growth resulting in large size at birth, adverse peri-
natal outcomes, and offspring adiposity [1]. Consistent
evidence shows that despite having a greater risk of de-
veloping GDM, South Asian women give birth to lower
weight infants than women of White European origin [2,
3]. This ethnic difference in weight appears to be present
in the fetus from as early as 20 weeks’ gestation based
on fetal ultrasound scan assessment [4–6].
Emerging evidence suggests that fetuses whose mothers
go on to be diagnosed with GDM may already show accel-
erated growth before this diagnosis is made. Diagnostic
testing, usually with an oral glucose tolerance test (OGTT),
is undertaken at 26–28 weeks, because this is the time in
pregnancy when there are detectable increases in insulin
resistance [7]. In a study of largely White European
women, faster hyperglycemia-related fetal growth was ob-
served between 20 and 28 weeks, i.e., prior to the diagnos-
tic test [8]. As there are effective and safe treatments for
GDM that reduce birth size and perinatal morbidity [7, 9,
10], this finding suggests that earlier diagnosis might have
clinical benefit. Whether a similar pattern of early growth
deviation by GDM status would be seen in South Asian
women who differ from White European women in fetal
growth characteristics and risk of developing GDM is un-
known. Moreover, as GDM is the upper end of a con-
tinuum of linear associations of increasing gestational
glucose with greater birth weight [11–13] it is plausible that
glucose levels below the diagnostic threshold will be related
to fetal growth. Understanding the joint associations of
GDM and South Asian ethnicity, two key risk factors for
variation in birthweight, on fetal growth is important for
identifying mechanisms that might explain lower birth-
weight in South Asians despite their greater GDM risk, and
also for determining whether hyperglycemia-related patho-
logical growth in South Asians can be determined from
fetal growth patterns.
The aim of this study was to determine the associa-
tions of GDM and gestational glucose with longitudinal
fetal growth across different parameters [head circumfer-
ence (HC), abdominal circumference (AC), femur length
(FL), and estimated fetal weight (EFW)] in White Euro-
pean and South Asian women.
Methods
Participants
We used data from the Born in Bradford (BiB) study, a
population-based prospective pregnancy cohort including
12,450 women who experienced 13,773 pregnancies [14].
The cohort is broadly representative of the obstetric popu-
lation in Bradford, a city in the north of England (UK), in
which approximately half of the births are to mothers of
South Asian origin. Eligible women had to have an ex-
pected delivery between March 2007 and December 2010
in the maternity department at Bradford Royal Infirmary
(BRI). Participants were recruited primarily at their oral
glucose tolerance test (OGTT) appointment, which is of-
fered to all women booked for delivery at the BRI. Univer-
sal OGTT diagnosis of GDM has been implemented at
the BRI since 2007 following a report by the Bradford
Mortality Commission highlighting the rising infant mor-
tality and poor health of pregnant women in Bradford
[15]. Women who agreed to participate in BiB completed
an interviewer-administered questionnaire, had their
height and weight measured, and consented to the ab-
straction of medical records and fetal ultrasonography
data. Ethical approval for the study was granted by the
Bradford National Health Service Research Ethics Com-
mittee (ref 06/Q1202/48), and all participants gave written
informed consent.
Figure S1 in Additional file 1 shows the flow of partici-
pants through the study. For this analysis, women had to
have a singleton pregnancy without known congenital
anomalies and with no history of pre-existing diabetes.
We further restricted the cohort to women of White
European and South Asian origin, as numbers from
other ethnic backgrounds were too small to be analyzed
separately. Following these exclusions, there were 11,697
eligible singletons, and of these 10,705 had data on
GDM and fetal ultrasound.
Assessment of fetal growth
Fetal ultrasound and birth anthropometric measure-
ments were collected as part of the NHS screening pro-
gram. In accordance with the National Institute for
Health and Care Excellence (NICE) guidelines for UK
antenatal care [16], women are invited to two routine
ultrasound examinations during the first and second tri-
mester: a “dating” scan performed between 10 weeks
and 0 days and 13 weeks and 6 days’ gestation (but earl-
ier and later gestational age assessment is common
dependent on when the pregnant woman first presents
to health services) and an “anomaly” scan which is of-
fered between 18 weeks and 0 days and 20 weeks and
6 days’ gestation. In the UK, third trimester scans are
not offered on a routine basis, but women deemed at a
higher risk of pregnancy complications are offered add-
itional scans, as required in the third trimester. In
addition to these routine scans, a random sample of
3749 BiB participants were invited for a third trimester
scan (at 32–34 weeks) as part of a sub-study investigat-
ing renal development [1806 (48%) completed the scan
and of these 1569 met our inclusion criteria and are part
of this study].
Brand et al. BMC Medicine          (2018) 16:203 Page 2 of 13
Based on UK ultrasonography recommendations [17],
gestational age was determined using crown-rump
length (CRL) up to 13 weeks 6 days, and head circum-
ference thereafter. Measurements of HC, FL, and AC
were done using standard ultrasound planes, and esti-
mated fetal weight (EFW) was derived using the Hadlock
1985 formula [18], which has been validated in Euro-
peans and South Asians [19]:
Log10 weight ¼ 1:326 0:00326 AC FL
þ0:0107 HCþ 0:0438 AC
þ0:158 FL
Infant HC, AC, and weight were measured within 24 h
following birth by a pediatrician or specially trained mid-
wife [20]. For the assessment of small (SGA) and large
for gestational age (LGA), we used non-customized birth
weight centiles (standardized by gestational age and sex)
according to Intergrowth-21st standards [21]. We add-
itionally defined SGA and LGA based on GROW cus-
tomized centile charts using the UK bulk calculator
from the Perinatal Institute [22]. As well as standardiz-
ing on gestational age and sex, these centiles also
standardize on maternal parity, weight, height, and eth-
nicity, assuming these characteristics to be physiological,
rather than pathological causes of SGA or LGA. In both
methods, SGA and LGA were defined by the 10th and
90th percentiles, respectively, in infants delivered be-
tween 24 and 42 weeks’ gestation. Some of the additional
data required for customization was missing and SGA
and LGA based on customized charts were calculated
for the 8318 with complete data on all parameters. To
enable comparisons between those with and without
complete data, we present results using the Intergrowth-
21st standards for women with full data and also for the
group in whom we were able to calculate SGA and LGA
using customized charts (n = 8313).
Maternal gestational diabetes and glucose levels
All women were offered a 75 g OGTT comprising over-
night fasting and 2-h postload samples, at around 26–
28 weeks [14]. Plasma glucose levels were assayed imme-
diately after sampling using the glucose oxidase method
on Siemen’s Advia 2400 chemistry autoanalyzers and
Siemen’s Advia Centaur assay. Coefficients of variation
range between 1.73% at 3.2 mmol/L and 0.64% at
19.1 mmol/L. GDM was defined according to modified
WHO criteria operating at the time of the study as ei-
ther fasting glucose ≥ 6.1 mmol/l or 2-h postload glucose
≥ 7.8 mmol/l [23].
Ethnicity
Maternal ethnicity was determined at recruitment using
interviewer-administered questionnaires, which asked
participants to indicate which of the UK Office of
National Statistics ethnicity categories best described
their ethnic origin. Data on women’s report of country
of their, their partners, and all four grandparents’ coun-
try of birth were used to verify their self-reported ethnic
origin. For women who did not have ethnicity data col-
lected at the recruitment interview, data were abstracted
from primary care medical records, which use a similar
categorization. Women classified as South Asian in-
cluded those who indicated they were Pakistani, Indian,
or Bangladeshi, and women classified as White European
included those who indicated that they were White Brit-
ish or other White European origin.
Covariates
Women were weighed and had their height measured (un-
shod and in light clothing) at recruitment (26–28 weeks’
gestation). Weight at the first antenatal clinic assessment
when women had a median gestational age of 12 weeks
[interquartile range (IQR) 11–14] was abstracted from the
antenatal records, and this weight together with the mea-
sured height at recruitment, was used to calculate the
woman’s early pregnancy BMI. Data on infant sex, parity,
hypertensive disorders of pregnancy, and still births were
abstracted from medical records. Information on maternal
age at delivery, education, smoking, and alcohol consump-
tion was derived from the interviewer-administered ques-
tionnaire at recruitment.
Statistical analyses
Analyses were undertaken using MLwiN version 2.4 run
in Stata version 15 [24]. Fetal growth trajectories were
estimated using 2-degree fractional polynomial models
in a multilevel framework [measurements within occa-
sions (level 1) within individuals (level 2)]. Full specifica-
tion of the models can be found in the Supplementary
Methods in Additional file 2, including supportive data
(Table S1 and Table S2 in Additional file 1) for the
growth trajectories fitted (Figure S2 in Additional file 1).
Differences in fetal growth by ethnicity and GDM/ges-
tational glucose were analyzed by adding these variables,
and their interactions with gestational age to the multi-
level models. Associations with gestational glucose in
those without GDM were assessed by analyzing fasting
and 2-h postload glucose levels as quintiles and per
standard deviation (SD) increase. Differences in fetal size
were estimated at 4-weekly intervals from 12/16 to
40 weeks’ gestation and are reported in absolute original
units (i.e., millimeters and grams) and proportionally as
the ratio of the observed difference to the mean at each
time point. Results are presented with adjustment for in-
fant sex (model 1) and with further adjustment for ma-
ternal age at delivery, parity, height, BMI, education
level, smoking and alcohol use during pregnancy, and
hypertensive disorders of pregnancy (model 2). Ethnic
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differences in associations between GDM/gestational
glucose and fetal growth were assessed by adding rele-
vant interaction terms to the models. In analyses of joint
associations of ethnicity and GDM, we compared White
European women with GDM, South Asian women with-
out GDM and South Asian women with GDM, to White
European women without GDM (the reference group).
Missing covariate data were imputed using multiple
imputation (see details in the supplementary methods in
Additional file 2), enabling a sample size of n = 10,700,
10,689, 10,520, and 10,701 for HC, FL, AC, and EFW re-
spectively. For comparison, we also ran all analyses using
complete case data (n = 8347, 8340, 8215, and 8349 for
HC, FL, AC, and EFW respectively). To assess the pos-
sible influence of large numbers of repeat measure-
ments, we did a sensitivity analysis limited to singletons
with ≤ 4 ultrasound scans. We also evaluated the poten-
tial influence of OGTT timing in an analysis excluding
pregnancies with an early (< 24 weeks) or late OGTT (>
30 weeks).
Results
Maternal and infant characteristics of participants ex-
cluded from analyses because of missing data on GDM
and/or ultrasound scan measures, were similar to those
included in our study (Table S3 in Additional file 1).
Characteristics of the analysis cohort by ethnicity and
GDM status are summarized in Table 1. In total, 832
pregnancies were affected by GDM (7.8%). The preva-
lence of GDM was higher in South Asians (10.4%) than
in White Europeans (4.4%), as were mean fasting and
2-h postload glucose levels (in those without GDM).
Compared to White Europeans, South Asian women
were shorter, had a lower BMI, higher parity, and were
considerably less likely to drink alcohol or smoke during
pregnancy. South Asian infants were also lighter at birth
and less likely to be LGA by Intergrowth-21st standards.
With GROW customized centile charts, the higher level
of LGA in White Europeans decreased such that levels
were similar to those in South Asians (as we might ex-
pect given these charts remove ethnic differences by as-
suming them to be physiological). Mean (SD) gestational
age at OGTT was 26 (2.0) weeks. In both ethnic groups,
women diagnosed with GDM were more likely to have a
higher BMI and shorter stature than normoglycemic
women, and infants of GDM pregnancies had a higher
birthweight with a larger proportion being LGA.
Table S2 in Additional file 1 summarizes the repeat
anthropometric measurements included in the analyses.
The median number of anthropometric measures per
fetus was 3 (IQR 2–4; full-range 1–12) and the mean
(SD) gestational age at first fetal anthropometric meas-
urement was 18.8 (3.1) weeks. As might be expected,
women with a third trimester scan were older, had a
higher BMI, were more often multiparous, and were
more likely to have diagnosis of GDM or hypertensive
disorder of pregnancy (Table S4 in Additional file 1). In-
fants of women with a third trimester scan were deliv-
ered with an earlier gestational age and had a lower
birthweight than infants of mothers who did not have a
third trimester scan (Table S4 in Additional file 1). In
total, 2341 participants did not have a CRL measure-
ment for dating and fetal HC was used to date these
women. Infants of the 2341 women who were “dated”
on the basis of HC rather than CRL had similar gesta-
tional ages at delivery and birthweights; their mothers
had similar mean BMI, height, fasting and postload glu-
cose, and rates of GDM and hypertensive disorder of
pregnancy. They were, however, more likely to be South
Asian, have a higher parity, lower education, and less
likely to smoke or drink alcohol in pregnancy (Table S5
in Additional file 1).
Ethnicity and fetal growth
Ethnic differences in fetal growth trajectories of HC, FL,
AC, and EFW are presented in Figure S3 in Additional file 1.
Except for FL, South Asian fetuses were smaller than
White European fetuses from 20 weeks’ gestation through
to birth, with the largest difference observed for AC and
EFW (Table 2 and Figure S3 in Additional file 1). Absolute
and proportional differences in fetal size increased with in-
creasing gestational age, and the difference in means (95%
CI) comparing South Asians to White Europeans for AC
and EFW were − 3.3 mm (− 4.0; − 2.5) and − 17 g (− 24; −
11) at 24 weeks, and − 12.4 mm (− 13.9; − 10.9) and −
206 g (− 232; − 180) at 40 weeks respectively. Mean differ-
ences in HC by ethnicity were smaller [− 1.0 mm (− 1.5; −
0.5) at 24 weeks and − 5.4 mm (− 6.1; − 4.6) at 40 weeks
comparing South Asians to White Europeans]. There was
also some evidence of South Asian fetuses having a greater
FL between 20 and 28 weeks’ gestation but not towards the
end of the third trimester.
GDM, gestational glucose, and fetal growth
Trajectories of individual fetal growth parameters by
GDM status are presented in Figure S4 in Additional file 1.
Fetuses of women who were later diagnosed with GDM
were smaller in early pregnancy [difference in mean HC at
12 weeks and mean AC and EFW at 16 weeks comparing
fetuses exposed to GDM to fetuses not exposed to GDM
(reference) = − 1.8 mm (− 2.6; 1.0), − 1.7 mm (− 2.5; − 0.9),
and − 6 g (− 10; − 2) respectively]. This pattern of early
growth restriction was followed by enhanced growth with
fetuses of GDM complicated pregnancies being larger at
24 weeks’ gestation [difference in means comparing
fetuses exposed to GDM vs. those unexposed were
0.9 mm (0.3; 1.4) for HC, 0.9 mm (0.2; 1.7) for AC and 7 g
(0; 13) for EFW respectively] (Table 2 and Figure S4 in
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Table 1 Characteristics of the singleton cohort by ethnicity and gestational diabetes status
White European South Asian
All (N = 4747) No GDM (N = 4537) GDM (N = 210) All (N = 5958) No GDM (N = 5336) GDM (N = 622)
Infant characteristics
Sex, % (N)
Male 51.7 (2455) 51.8 (2351) 49.5 (104) 51.5 (3069) 51.4 (2743) 52.4 (326)
Female 48.3 (2292) 48.2 (2186) 50.5 (106) 48.5 (2889) 48.6 (2593) 47.6 (296)
Ethnicity by country, % (N)
White British 92.6 (4396) 92.7 (4204) 91.4 (192) – – –
White other 7.4 (351) 7.3 (333) 8.6 (18) – – –
Pakistani – – – 87.0 (5181) 87.1 (4649) 85.5 (532)
Indian – – – 7.2 (43) 7.4 (392) 6.4 (40)
Bangladeshi – – – 5.8 (345) 5.5 (295) 8.0 (50)
Birthweight (g), mean (SD) 3354 (550) 3359 (551) 3246 (450) 3140 (515) 3145 (517) 3094 (489)
Missing, % (N) 0.2 (8) 0.2 (8) 0 (0) 0.03 (2) 0.04 (2) 0 (0)
Gestational age at birth (years), mean (SD) 39.3 (1.8) 39.4 (1.8) 38.1 (1.5) 39.1 (1.7) 39.2 (1.7) 38.2 (1.3)
Missing, % (N) 0.2 (8) 0.2 (8) 0 (0) 0.03 (2) 0.04 (2) 0 (0)
Intergrowth birth weight centiles (full cohort analyses), % (N)*
SGA (< 10th) 8.0 (377) 8.1 (368) 4.3 (9) 16.2 (962) 16.7 (891) 11.4 (71)
LGA (> 90th) 14.9 (707) 14.8 (669) 18.1 (38) 7.0 (419) 6.6 (354) 10.5 (65)
Missing 0.2 (8) 0.2 (8) 0 (0) 0.03 (2) 0.04 (2) 0 (0)
Intergrowth birth weight centiles (restricted analyses), % (N)*
SGA (< 10th) 7.1 (275) 7.3 (268) 3.6 (7) 16.4 (730) 17.0 (677) 11.3 (53)
LGA (> 90th) 15.1 (584) 15.0 (552) 16.8 (32) 6.7 (297) 6.2 (246) 10.8 (51)
Missing 18.6 (884) 19.0 (864) 9.5 (20) 25.3 (1508) 25.4 (1357) 24.3 (151)
Customized birth weight centiles, % (N)**
SGA (< 10th) 16.4 (634) 16.7 (614) 10.5 (20) 15.0 (670) 15.5 (617) 11.3 (53)
LGA (> 90th) 4.8 (186) 4.6 (170) 8.4 (16) 6.0 (269) 5.5 (220) 10.4 (49)
Missing 18.6 (884) 19.0 (864) 9.5 (20) 25.3 (1508) 25.4 (1357) 24.3 (151)
Maternal characteristics
Age at delivery (years), mean (SD) 26.7 (6.0) 26.6 (6.0) 30.2 (5.4) 28.0 (5.1) 27.7 (5.0) 30.7 (5.3)
Parity, % (N)
Primiparous 48.5 (2238) 48.6 (2144) 46.1 (94) 32.1 (1843) 32.9 (1692) 25.0 (151)
1 30.6 (1413) 30.6 (1349) 31.4 (64) 27.5 (1577) 28.3 (1455) 20.2 (122)
2 13.1 (603) 13.0 (573) 14.7 (30) 20.5 (1180) 20.3 (1045) 22.4 (135)
≥ 3 7.8 (358) 7.8 (342) 7.8 (16) 19.9 (1145) 18.5 (949) 32.5 (196)
Missing 2.8 (135) 2.8 (129) 2.9 (6) 3.6 (213) 3.7 (195) 2.9 (18)
Height (cm), mean (SD) 164.1 (6.2) 164.2 (6.3) 163.8 (6.1) 159.4 (5.8) 159.6 (5.8) 157.9 (5.8)
Missing, % (N) 12.6 (598) 12.9 (587) 5.2 (11) 18.3 (1090) 18.4 (981) 17.5 (109)
Body mass index (kg/m2), mean (SD) 26.6 (6.0) 26.5 (5.9) 28.6 (6.3) 25.5 (5.4) 25.2 (5.3) 28.2 (5.8)
Missing, % (N) 14.5 (689) 14.9 (674) 7.1 (15) 19.6 (1166) 19.6 (1046) 19.3 (120)
Education, % (N)
< 5 GCSEs 19.4 (799) 19.6 (770) 14.7 (29) 24.7 (1208) 23.9 (1045) 31.5 (163)
5 GCSEs 34.1 (1404) 34.4 (1350) 27.4 (54) 30.9 (1513) 30.9 (1353) 31.0 (160)
A-level 17.3 (714) 17.4 (681) 16.8 (33) 12.8 (625) 13.3 (583) 8.1 (42)
Higher than A-level 20.8 (857) 20.3 (796) 31.0 (61) 28.4 (1389) 28.7 (1255) 25.9 (134)
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Additional file 1). From 24 weeks to delivery, absolute and
proportional differences in AC and EFW increased with
increasing gestational age [mean differences associated
with GDM at 40 weeks’ gestation were 5.1 mm (3.5–6.8)
and 171 g (140; 202) respectively], while the larger HC ob-
served at 24 weeks attenuated towards the end of preg-
nancy and was no longer detectable at term (mean
difference = 0.1 mm (− 0.8; 1.1) at 40 weeks). The FL
growth trajectory did not notably differ by GDM status
across pregnancy.
To evaluate whether associations of GDM with fetal
growth are continuous across the glucose distribution, we
also assessed associations with gestational fasting and 2-h
postload glucose levels in women who were not diagnosed
with GDM. These results are presented in Table S6 in
Additional file 1; Figure S5 and S6 in Additional file 1.
Gestational glucose levels were positively and linearly as-
sociated with fetal AC and EFW starting from 20 to
24 weeks’ gestation and also with fetal HC from 28 weeks’
gestation. Overall, associations with HC, AC, and EFW
were somewhat weaker for 2-h postload glucose than fast-
ing glucose levels. While the mean difference in fetal HC
observed with GDM did not persist to term, gestational
glucose levels below the diagnostic threshold were posi-
tively associated with fetal HC until birth. As with
GDM, there was no clear evidence of gestational glu-
cose being associated with FL trajectories (Table S6 in
Additional file 1; Figure S5 and S6 in Additional file 1).
Joint associations of ethnicity and GDM with fetal growth
Figure 1 shows the observed mean differences in fetal
size across gestation by GDM in each ethnic group.
There was no evidence of effect modification by ethni-
city, as the direction and magnitude of associations of
GDM with fetal growth were similar in South Asians
and White Europeans, as were associations with postload
glucose in those not diagnosed with GDM (Figure S5 in
Additional file 1). Positive associations of fasting glu-
cose with fetal growth were somewhat stronger in
White European than South Asian fetuses, but as with
GDM, broadly similar in each ethnic group (Figure S6 in
Additional file 1).
As the association of GDM with fetal growth did
not differ by ethnicity, and South Asians were con-
sistently smaller in size than White Europeans across
pregnancy for most growth measures (independently
Table 1 Characteristics of the singleton cohort by ethnicity and gestational diabetes status (Continued)
White European South Asian
All (N = 4747) No GDM (N = 4537) GDM (N = 210) All (N = 5958) No GDM (N = 5336) GDM (N = 622)
Other 8.3 (343) 8.2 (323) 10.2 (20) 3.3 (163) 3.3 (145) 3.5 (18)
Missing 13.3 (630) 13.6 (617) 6.2 (13) 17.8 (1060) 17.9 (955) 16.9 (105)
Maternal characteristics
Smoking during pregnancy, % (N)
No 67.4 (2836) 67.0 (2682) 76.2 (154) 96.8 (4817) 96.8 (4307) 96.6 (510)
Yes 32.6 (1371) 33.0 (1323) 23.8 (48) 3.2 (159) 3.2 (141) 3.4 (18)
Missing 11.4 (540) 11.7 (532) 3.8 (8) 16.5 (982) 16.6 (888) 15.1 (94)
Any alcohol during pregnancy, % (N)
No 33.3 (1399) 33.1 (1323) 37.6 (76) 98.7 (4908) 98.7 (4389) 98.5 (519)
Yes 66.7 (2802) 66.9 (2676) 62.4 (126) 1.4 (67) 1.3 (59) 1.5 (8)
Missing 11.5 (546) 11.9 (538) 3.8 (8) 16.5 (983) 16.6 (888) 15.3 (95)
Fasting glucose (mmol/L), mean (SD) 4.40 (0.41) 4.39 (0.37) 4.86 (0.82) 4.63 (0.61) 4.53 (0.42) 5.42 (1.17)
Missing 10.0 (475) 10.3 (468) 3.3 (7) 8.0 (479) 8.1 (448) 5.0 (31)
2-h postload glucose (mmol/L), mean (SD) 5.44 (1.28) 5.28 (1.07) 8.55 (1.20) 5.88 (1.64) 5.48 (1.02) 9.13 (2.13)
Missing 10.1 (481) 10.4 (474) 3.3 (7) 8.2 (486) 8.5 (455) 5.0 (31)
Hypertensive disorders of pregnancy, % (N)
No 93.3 (4427) 93.3 (4231) 93.3 (196) 94.7 (5644) 94.8 (5057) 94.4 (587)
Yes 6.7 (320) 6.7 (306) 6.7 (14) 5.3 (314) 5.2 (279) 5.6 (35)
GDM gestational diabetes, SD standard deviation, GCSE General Certificate of Secondary Education. *SGA- and LGA-defined based on non-customized birth weight
centiles (standardized on sex and gestational age only) according to Intergrowth-21st standards. **SGA- and LGA-defined based on GROW customized birth
weight centiles (standardized on sex, gestational age, maternal parity, height, and weight). For the Intergrowth-21st (non-customized) charts, we present results
for the maximal sample (n = 10,695) and for the smaller sample (n = 8313 with no missing data on maternal parity, height, and weight) used for comparison with
customized birth weight centiles. Please note that the Intergrowth-21st standards and GROW customized birth weight centiles use different methods, with
different principles regarding health birth size. Thus, even where two proportions are similar, it is likely that different participants contribute to the cases of SGA
and LGA
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Table 2 Predicted mean differences of fetal parameters by ethnicity and gestational diabetes at different time points during gestation
Predicted mean difference (95% CI)
HC (mm) N 12 weeks 24 weeks 40 weeks
Ethnicity
White European 4744 Ref Ref Ref
South Asian 5956 0.3 (− 0.5; 1.0) − 1.0 (− 1.5; − 0.5) − 5.4 (− 6.1; − 4.6)
GDM
No 9868 Ref Ref Ref
Yes 832 − 1.8 (− 2.6; − 1.0) 0.9 (0.3; 1.4) 0.1 (− 0.8; 1.1)
Ethnicity/GDM
White European/no GDM 4534 Ref Ref Ref
White European/GDM 210 − 2.7 (− 4.3; − 1.1) 1.5 (0.5; 2.6) 0.1 (− 1.7; 1.9)
South Asian/no GDM 5334 0.2 (− 0.6; 0.9) − 0.9 (− 1.4; − 0.4) − 5.3 (− 6.1; − 4.5)
South Asian/GDM 622 − 1.4 (− 2.5; − 0.3) − 0.3 (− 1.0; 0.5) − 5.2 (− 6.5; − 4.0)
FL (mm) N 12 weeks 24 weeks 40 weeks
Ethnicity
White European 4740 Ref Ref Ref
South Asian 5949 0.1 (− 0.2; 0.5) 0.3 (0.1; 0.4) 0.0 (− 0.4; 0.3)
GDM
No 9857 Ref Ref Ref
Yes 832 − 0.6 (− 0.9; − 0.3) 0.1 (− 0.1; 0.2) 0.1 (− 0.2; 0.4)
Ethnicity/GDM
White European/no GDM 4530 Ref Ref Ref
White European/GDM 210 0.1 (− 0.6; 0.7) 0.1 (− 0.2; 0.4) 0.6 (0.1; 1.1)
South Asian/no GDM 5327 0.2 (− 0.1; 0.6) 0.3 (0.1; 0.4) 0.1 (− 0.3; 0.4)
South Asian/GDM 622 − 0.6 (− 1.1; − 0.2) 0.3 (0.1; 0.5) 0.0 (− 0.5; 0.4)
AC (mm) N 16 weeks 24 weeks 40 weeks
Ethnicity
White European 4648 Ref Ref Ref
South Asian 5872 − 1.5 (− 2.3; − 0.8) − 3.3 (− 4.0; − 2.5) − 12.4 (− 13.9; − 10.9)
GDM
No 9690 Ref Ref Ref
Yes 830 − 1.7 (− 2.5; − 0.9) 0.9 (0.2; 1.7) 5.1 (3.5; 6.8)
Ethnicity/GDM
White European/no GDM 4438 Ref Ref Ref
White European/GDM 210 − 2.2 (− 3.7; − 0.7) 0.9 (− 0.5; 2.3) 4.3 (1.1; 7.5)
South Asian/no GDM 5252 − 1.6 (− 2.4; − 0.8) − 3.2 (− 4.0; − 2.5) − 12.5 (− 14.0; − 11.0)
South Asian/GDM 620 − 3.1 (− 4.3; − 2.0) − 2.3 (− 3.4; − 1.2) − 7.1 (− 9.4; − 4.8)
EFW (g) N 16 weeks 24 weeks 40 weeks
Ethnicity
White European 4745 Ref Ref Ref
South Asian 5956 2 (− 2; 6) − 17 (− 24; − 11) − 206 (− 232; − 180)
GDM
No 9869 Ref Ref Ref
Yes 832 − 6 (− 10; − 2) 7 (0; 13) 171 (140; 202)
Ethnicity/GDM
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of GDM), South Asian fetuses exposed to GDM were
smaller across gestation than White European fetuses not
exposed to GDM (Fig. 2, Table 2). This difference was lar-
gest for AC and EFW and detectable from early pregnancy
[difference in mean AC and EFW at 24 weeks comparing
South Asians exposed to GDM to White Europeans not
exposed to GDM= − 2.3 mm (− 3.4; − 1.2) and − 10 g (−
19; − 1) respectively] and increased as pregnancy pro-
gressed, such that by term (40 weeks) it was − 7.1 mm (−
9.4; − 4.8) for AC and − 45 g (− 86; − 4) for EFW.
All results presented above are from multivariable ad-
justed analyses following multiple imputation for missing
Table 2 Predicted mean differences of fetal parameters by ethnicity and gestational diabetes at different time points during gestation
(Continued)
Predicted mean difference (95% CI)
White European/no GDM 4535 Ref Ref Ref
White European/GDM 210 − 3 (− 11; 4) 5 (− 6; 17) 204 (145; 263)
South Asian/no GDM 5334 2 (− 2; 6) − 17 (− 24; − 11) − 203 (− 230; − 177)
South Asian/GDM 622 − 5 (− 11; 0) − 10 (− 19; − 1) − 45 (− 86; − 3)
Separate and joint associations of ethnicity and gestational diabetes with fetal growth trajectories, presented as mean differences of head circumference (HC),
femur length (FL), abdominal circumference (AC), and estimated fetal weight (EFW) during early (12/16 weeks), mid (24 weeks), and late (40 weeks) gestation. All
mean differences are estimated using multilevel fractional polynomial models with adjustment for infant sex, maternal age at delivery, parity, height, body mass
index, education level, smoking, and alcohol use during pregnancy, and hypertensive disorders of pregnancy. Models were additionally adjusted for gestational
diabetes [in analyses examining mean differences by ethnicity (White European vs. South Asian)] and ethnicity [in analyses examining mean differences by
gestational diabetes (yes vs. no)]. GDM gestational diabetes, CI confidence interval
Fig. 1 Associations of gestational diabetes with fetal growth across gestation in White Europeans and South Asians. Predicted differences in
mean head circumference (mm), femur length (mm), abdominal circumference (mm), and estimated fetal weight (g) comparing fetuses exposed
to gestational diabetes to those not exposed to gestational diabetes (reference group) across gestation. Predicted mean differences are given for
the total study population and for each ethnic group (White European and South Asian). All estimates are derived from multivariable models with
adjustment for infant sex, maternal age at delivery, ethnicity, parity, height, body mass index, education level, smoking, and alcohol use during
pregnancy and hypertensive disorders of pregnancy. Positive mean differences (larger than 0) indicate larger size in fetuses exposed to gestational diabetes
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covariable data; associations were similar in analyses
with adjustment for infant sex only (Table S7 in
Additional file 1) and in complete case analyses (Table S8
in Additional file 1). They were also similar when limited
to women with ≤ 4 repeat ultrasound scans (Table S9 in
Additional file 1) and when limited to women who com-
pleted the OGTT between 24 and 30 weeks’ gestation
(Table S10 in Additional file 1).
Discussion
In this prospective pregnancy cohort, we found that fe-
tuses of women subsequently diagnosed with GDM were
smaller at 12–16 weeks’ gestation but grew faster such
that from 24 weeks to delivery time, they had greater AC
and EFW compared with fetuses not exposed to GDM.
The association of GDM with fetal growth was of similar
magnitude in both ethnic groups and was also observed
across the distribution of fasting and postload glucose
levels in women without GDM. Growth trajectories dif-
fered by ethnicity irrespective of GDM status, with South
Asian fetuses being smaller from 20 weeks’ gestation to
term, than White European fetuses. Consequently, South
Asian fetuses exposed to GDM were on average smaller
across gestation than White European fetuses not exposed
to GDM. These findings indicate that hyperglycemia-asso-
ciated fetal growth deviations are detectable early in preg-
nancy prior to the usual time of GDM diagnostic testing
and that universal criteria for fetal growth assessment may
be inadequate for identifying GDM-associated patho-
logical effects in South Asians.
The observation of South Asians having a smaller fetal
size across gestation than White Europeans is consistent
with observations in other population-based studies
[4–6, 25]. Ethnic differences in fetal size increased as the
pregnancy progressed and were relatively more profound
for AC and EFW than for HC. It has been suggested that
the slower fetal growth in South Asians represents com-
promised growth and development of abdominal visceral
organs with relative sparing of the fetal brain to improve
survival chances in environments where nutritional re-
sources may be limited, with this being driven by fetal ad-
aptations to generations of maternal undernutrition
[6, 26]. The fact that we see larger ethnic differences for
AC and EFW than HC provides some support for this
Fig. 2 Joint associations of ethnicity and gestational diabetes with fetal growth. Average predicted growth trajectories of head circumference (A),
femur length (B), abdominal circumference (C), and estimated fetal weight (D) stratified by ethnic origin (South Asian vs. White European) and
gestational diabetes status (yes vs. no). All growth trajectories are estimated using multilevel fractional polynomial models with adjustment for
infant sex, maternal age at delivery, parity, height, body mass index, education levels, smoking, and alcohol use during pregnancy, and hypertensive
disorders of pregnancy.
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hypothesized mechanism. South Asian infants are, how-
ever, more adipose at birth on an absolute scale and also
relative to their birth weight compared to White European
infants [27, 28]. This “thin-fat phenotype” has also been
observed in South Asian infants born in the UK and com-
pared with White European infants born in the UK (in-
cluding from the same city and treated in the same
antenatal care setting) [3, 29]. It appears to persist through
infancy and early childhood [30]. Since our study was
based on standard ultrasound anthropometric measure-
ments, we were unable to distinguish fetal fat and lean
mass growth trajectories.
While the impact of GDM on birthweight is well-
established [12, 31], few studies have assessed the timing
at which divergent growth patterns emerge in utero [8,
32, 33]. Our findings of a larger fetal AC at 24 weeks’
gestation in women later diagnosed with GDM is con-
sistent with previous observations in White European
women [8], and support the notion that glycemia-related
fetal growth acceleration precedes the usual time of
OGTT to diagnose GDM. For the first time, we demon-
strate a similar pattern of increased fetal size preceding
the GDM diagnosis in South Asian origin women. Con-
sistent with previous data on offspring birth weight [11–
13], associations with GDM were part of a continuum as
gestational glucose levels were positively and linearly as-
sociated with fetal size from 24 weeks onwards. The
continuous positive association of gestational glucose
across the whole distribution with fetal growth and birth
weight, including in two ethnic groups with very differ-
ent body compositions, likely reflects the facilitated dif-
fusion of glucose across the placenta and the fetal
insulin secretion response to this. The diagnostic criteria
for GDM aim to minimize LGA and associated adverse
outcomes, while not compromising healthy fetal growth
and development, and the associations of fasting and
postload glucose with fetal growth and birth weight in
women who do not meet criteria for a diagnosis of
GDM do not imply the thresholds for diagnosing GDM
should be reduced. Our results do support developing
methods for identifying hyperglycemia-related adverse
fetal growth in early pregnancy.
We further found evidence that fetuses of GDM com-
plicated pregnancies were smaller at 12 and 16 weeks’
gestation prior to the onset of growth acceleration. This
biphasic fetal growth pattern with early fetal growth re-
striction predating growth acceleration has previously
been described in GDM [32], pre-gestational type 1 [34, 35],
and type 2 diabetes [33] and has been attributed to transient
oxygen tension in early pregnancy with oxidative and/or pro-
inflammatory stress superimposed by hyperglycemia exerting
a short-term inhibitory effect on trophoblast and placental
growth [36]. In our cohort, there were too few women (67 in
total; 36 South Asian, 24 White European, and 7 other
ethnic origin) to be able to explore fetal growth trajectories
by pre-gestational diabetes.
Oral glucose tolerance tests for diagnosis of GDM are
undertaken at 26–28 weeks because this is the time in
pregnancy when there are detectable increases in insulin
resistance [7]. However, GDM is likely to reflect the
unmasking of a predisposition to hyperglycemia and type
2 diabetes as a result of pregnancy changes mimicking a
glucose stress test [37]. This would be in line with reports
linking pregestational increased glucose levels [38] and re-
ductions in peripheral insulin sensitivity [39, 40] to a
GDM diagnosis later in pregnancy. The International As-
sociation of the Diabetes and Pregnancy Study Groups’ cri-
teria recommend a random fasting glucose measure in the
first antenatal clinic visit which could identify women with
pre-existing hyperglycemia and support earlier monitoring
and treatment. Given we have shown GDM-associated fetal
growth alterations as early as 12–16 weeks’ gestation, and
other studies show early growth retardation in relation to
existing type 1 and type 2 diabetes [33–35], efforts to im-
prove pre- and periconceptional maternal health deserve
more attention in the prevention of adverse pregnancy out-
comes including hyperglycemia-related fetal growth
differences [41, 42].
Despite the fact that South Asian women have higher
fasting and postload glucose levels and are more likely
to develop GDM [11], their infants weigh on average less
at birth than infants of White European mothers. Here,
we show that the fetal growth difference between South
Asians and White Europeans is substantial as, on aver-
age, infants of South Asian women with GDM were even
smaller across gestation than infants of White Europeans
without GDM. There are a number of implications that
follow from this. First, this could result in South Asian
fetuses and infants with glycemia-related pathological
fetal growth not being identified as such. This can be
seen by the proportions identified as LGA based on birth
weight in this study. Applying the Intergrowth-21st stan-
dards, which assess the deviation in birth weight from
an ideal size that would be obtained under extreme
healthy pregnancy conditions (no complications, within
a tightly defined age, height and BMI range, and healthy
behaviors such as not smoking in pregnancy), showed
higher proportions of LGA in infants of mothers with
GDM compared to those without GDM in both ethnici-
ties and also lower rates of LGA in South Asians
compared with White Europeans, consistent with the dif-
ferences in fetal growth that we find by GDM and ethni-
city. By contrast, customized reference charts (which
assume that maternal ethnicity, as well as height, weight,
and parity are physiological causes of variation in birth-
weight and remove the effects of these characteristics on
SGA and LGA) removed the ethnic difference in LGA, as
expected given the standardization on ethnicity. Whatever
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standard or reference charts are used, it may be that lower
thresholds for fetal growth and birth weight are necessary
to identify South Asians at risk of LGA and potential fu-
ture risk of obesity. However, such an approach could risk
missing cases of SGA and the use of ethnic specific
thresholds would only be justified if this would also im-
prove the prediction of adverse neonatal outcomes related
to SGA, which remains to be determined. In light of the
ongoing debate around universal fetal growth standards
vs. reference charts (whether customized or not), further
studies addressing this important knowledge gap are war-
ranted [43]. Second, our findings suggest that routine fetal
ultrasound measures may be inadequate for the assess-
ment of GDM pathological effects if these are largely
driven by other anthropometric measures. Infants born to
mothers with GDM have a higher fat to lean body mass
[44, 45] and a predisposition to fat over fat-free mass has
also been demonstrated in utero from 20 weeks’ gestation
[46, 47]. Evidence from the BiB cohort further suggests
that higher cord blood leptin levels, a proxy for fetal fat
mass, in South Asian compared with White European in-
fants is largely driven by the ethnic difference in maternal
glucose levels [23]. Taken together, these data indicate that
more detailed fetal body composition measures (distin-
guishing fetal fat from lean mass trajectories) may be im-
portant in identifying pathological effects of gestational
hyperglycemia and to ascertain whether “normal” weight
South Asian infants of GDM pregnancies might be a
group at risk of adverse perinatal and long-term metabolic
health.
Strengths of this study are the large sample size, repeat
ultrasound measurements of fetal growth from 12/
16 weeks of gestation to birth, and the ability to examine
joint effects of GDM and ethnicity. Our study was em-
bedded in routine clinical practice with universal OGTT
diagnostic testing, which allowed us to determine associ-
ations with gestational hyperglycemia across the entire
glucose range. Third trimester ultrasound scans, how-
ever, were only available for a subset of the cohort.
Nonetheless, ~ 30% of all third trimester scans were re-
search scans and not done because of clinical indication,
almost all infants had birth measurements as the fetal
growth endpoint and exclusion of singletons with ≥ 4
ultrasound scans (which addresses the impact of clinical
indications associated with multiple repeat scans) did
not change the results. Moreover, all analyses were ad-
justed for a wide range of maternal characteristics, some
of which were also predictive of having an additional
third trimester scan. This means that the “missing at
random” assumption is plausible, minimizing any poten-
tial bias.
Gestational age assessment in our study was based on
fetal biometry which relies on the assumption that vari-
ation between fetuses is negligible during the dating
period. This could have resulted in an underestimation
of fetal size variation in early pregnancy and conse-
quent inability to detect associations at this time, es-
pecially where fetal HC was used for dating.
However, only 22% of all participants had missing
CRL data, and it is unlikely that the use of HC for
dating has resulted in major bias as mean gestational
age at delivery, birth weight, GDM, and fasting and
postload glucose were similar between those whose
dates were derived from CRL and those from HC.
However, the ethnic imbalance in dating method
used could have masked the ethnic difference in fetal
HC trajectory observed, especially during early gesta-
tion when fetal HC measurements are more closely corre-
lated to the dating measure. Finally, we cannot exclude
the possibility of a systematic over- or underestima-
tion of early fetal size differences between women
with and without GDM. This is an inherent source of
potential bias related to the fact that pregnancy dat-
ing is performed without knowing whether or not a
woman will or will not experience GDM. As fetal size
is used to allocate a gestational age, a lower or higher
gestational age may have been assigned to GDM cases
if their fetus was already smaller or larger than fe-
tuses of women without GDM at the dating scan.
The consequence of pregnancy dating being pushed
backward or forward in these women is that the ac-
tual size of their fetus at a given gestational age in
early pregnancy (when fetal anthropometric measures
are closely correlated to CRL and HC measures used
for dating) could have been overestimated or underes-
timated relative to the fetal size of normoglycemic
women. Finally, we were unable to assess associations
with early pregnancy glucose, as this was not mea-
sured in the BiB cohort.
Conclusions
GDM is associated with fetal growth deviation in early
pregnancy prior to diagnosis in both ethnic groups.
This emphasizes the need for novel strategies to diag-
nose hyperglycemia-related growth accelerations earlier
than current methods. Consistent with the hypothesis
that South Asian fetuses adapt to generations of mater-
nal undernutrition by compromising growth and devel-
opment of abdominal visceral organs with relative
sparing of the fetal brain, we found greater ethnic
differences between AC and EFW than with HC, but
further research is required to understand ethnic differ-
ences in fetal growth of fat, lean, and skeletal mass. Fur-
thermore, as fetal growth trajectories differ considerably
by ethnicity and this could potentially mask the detec-
tion of hyperglycemia-related pathological effects, fur-
ther work is now needed to understand how this may
influence perinatal and offspring health.
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